Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
CN |
|
Golden Eagle Energy Tbk PT
IDX:SMMT
|
ID |
|
O
|
Orezone Gold Corp
TSX:ORE
|
CA |
|
E
|
Elanco Animal Health Inc
SWB:5EA
|
US |
|
Shenzhen Guangju Energy Co Ltd
SZSE:000096
|
CN |
|
COSCO Shipping Holdings Co Ltd
SSE:601919
|
CN |
|
F
|
Firm Capital Apartment Real Estate Investment Trust
XTSX:FCA.U
|
CA |
|
Nexgel Inc
NASDAQ:NXGL
|
US |
|
Coca-Cola Europacific Partners PLC
NASDAQ:CCEP
|
UK |
|
Saurer Intelligent Technology Co Ltd
SSE:600545
|
CN |
|
P
|
Proud Real Estate PCL
SET:PROUD
|
TH |
|
Saudi Telecom Company SJSC
SAU:7010
|
SA |
|
C
|
Computer and Technologies Holdings Ltd
HKEX:46
|
HK |
|
V
|
VRL Logistics Ltd
BSE:539118
|
IN |
|
S
|
S2Medical AB (publ)
STO:S2M
|
SE |
|
American Battery Materials Inc
OTC:BLTH
|
US |
|
Keyware Technologies NV
XBRU:KEYW
|
BE |
Wall Street
Price Targets
Price Targets Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
According to Wall Street analysts, the average 1-year price target for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is 51 CNY
with a low forecast of 50.5 CNY and a high forecast of 52.5 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's stock price target?
Price Target
51
CNY
According to Wall Street analysts, the average 1-year price target for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
is 51 CNY
with a low forecast of 50.5 CNY and a high forecast of 52.5 CNY.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Revenue forecast?
Projected CAGR
7%
For the last 6 years the
compound annual growth rate for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's revenue is
15%.
The projected
CAGR
for the next 2 years is
7%.
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd's Net Income forecast?
Projected CAGR
-22%
For the last 6 years the
compound annual growth rate for
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's net income is
-16%.
The projected
CAGR
for the next 2 years is
-22%.
